APA (7th ed.) Citation

Sinha, S., Ajayababu, A., Thukral, H., Gupta, S., Guha, S. K., Basu, A., . . . Tewari, S. (2022). Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): A Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial. Infectious Diseases & Therapy, 11(6), 2205. https://doi.org/10.1007/s40121-022-00703-y

Chicago Style (17th ed.) Citation

Sinha, Sanjeev, et al. "Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): A Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial." Infectious Diseases & Therapy 11, no. 6 (2022): 2205. https://doi.org/10.1007/s40121-022-00703-y.

MLA (9th ed.) Citation

Sinha, Sanjeev, et al. "Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): A Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial." Infectious Diseases & Therapy, vol. 11, no. 6, 2022, p. 2205, https://doi.org/10.1007/s40121-022-00703-y.